Foresite Capital Management VI »

Beam Therapeutics shares owned by Foresite Capital Management VI

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Foresite Capital Management VI from 13F filings

Historical chart of Foresite Capital Management VI investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Foresite Capital Management VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Foresite Capital Management VI

Quarter filed Position value Share count Share price at filing
2026-06-30 $11M 330k 34.32